William F. Owen
Director/Board Member at Association of Academic Health Centers
Profile
Dr. William F.
Owen, Jr. MD, is a Director at New Jersey Health Foundation, Inc. He is on the Board of Directors at Association of Academic Health Centers and Savient Pharmaceuticals, Inc.
Dr. Owen received his undergraduate degree from Brown University and a doctorate degree from Tufts University.
William F. Owen active positions
| Companies | Position | Start |
|---|---|---|
Association of Academic Health Centers
 Association of Academic Health Centers Miscellaneous Commercial ServicesCommercial Services Part of The Association of American Medical Colleges, Association of Academic Health Centers is a medical education, research, and healthcare organization based in Washington. The American company's mission is to provide tomorrow's doctors with tomorrow's cures. The private company offers resources and updates for the AAMC community on the coronavirus pandemic. The company was founded in 1980, and Steven L. Kanter has been the CEO of the company since 2018. The company was acquired by The Association of American Medical Colleges on April 01, 2022. | Director/Board Member | 2010-09-27 |
| Ross University School of Medicine | Corporate Officer/Principal | 2017-02-28 |
Former positions of William F. Owen
| Companies | Position | End |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Director/Board Member | 2013-01-06 |
| New Jersey Health Foundation, Inc. | Corporate Officer/Principal | - |
Training of William F. Owen
| Tufts University | Doctorate Degree |
| Brown University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Association of Academic Health Centers
Association of Academic Health Centers Miscellaneous Commercial ServicesCommercial Services Part of The Association of American Medical Colleges, Association of Academic Health Centers is a medical education, research, and healthcare organization based in Washington. The American company's mission is to provide tomorrow's doctors with tomorrow's cures. The private company offers resources and updates for the AAMC community on the coronavirus pandemic. The company was founded in 1980, and Steven L. Kanter has been the CEO of the company since 2018. The company was acquired by The Association of American Medical Colleges on April 01, 2022. | Commercial Services |
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
| New Jersey Health Foundation, Inc. | Finance |
- Stock Market
- Insiders
- William F. Owen